Next Article in Journal
Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
Next Article in Special Issue
Genome-Wide Analysis of DNA Methylation and Expression of MicroRNAs in Breast Cancer Cells
Previous Article in Journal
Supercritical Fluid Extraction of Eucalyptus globulus Bark—A Promising Approach for Triterpenoid Production
Previous Article in Special Issue
O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2012, 13(6), 7663-7675;

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer

Department of Respiratory Medicine, The Second Hospital Affiliated to Dalian Medical University, Dalian 116023, China
Department of Thoracic Surgery, The First Hospital Affiliated to Dalian Medical University, No. 222 Zhongshan Road, Dalian 116011, China
People’s Military Medical Press, Beijing Fuxing Road 22 A3, Beijing 100842, China
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 11 April 2012 / Revised: 15 June 2012 / Accepted: 19 June 2012 / Published: 21 June 2012
(This article belongs to the Special Issue Advances in Molecular Oncology (special issue))
Full-Text   |   PDF [407 KB, uploaded 19 June 2014]


Sox2 and Oct4 are transcription factors with the characteristics of regulating self-renewal and differentiation of embryonic stem cell. The aim of this study was to detect the expression of Sox2 and Oct4 and analyze their clinical significance in human non-small-cell lung cancer (NSCLC). Expression of Sox2 and Oct4 were assayed in cancer tissues and their corresponding paracancerous tissues from 44 patients with NSCLC and 21 patients with benign tumors using immunohistochemistry, Western blot, reverse transcription polymerase chain reaction (RT-PCR). The correlation between the expression of Sox2 and Oct4 and tumor type, grade and prognosis and the utility of the two genes in discriminating between benign and malignant tumors were analyzed as well. The results showed that Sox2 and Oct4 positive staining was only seen in the nuclei of cancer cells but not in either the precancerous tissues or benign tumor tissues by immunohistochemistry (p < 0.01). Furthermore, in the lung cancer tissue, the positive rate for Sox2 and Oct4 was 70.5% and 54.5%, respectively. Meanwhile, clinicopathological correlations showed that the Oct4 expression level was significantly associated with poorer differentiation and higher TNM stage of the cancer (p < 0.05). Western blot and RT-PCR analysis showed similar results to immunohistochemistry. Follow-up analysis revealed that expression of Oct4 was significantly associated with poor prognosis of lung cancer. The conclusion is that Sox2 and Oct4 may act as the promising unit markers in directing NSCLC diagnosis and therapy. Also, Oct4 can be regarded as a novel predictor of poor prognosis for NSCLC patients undergoing resection. View Full-Text
Keywords: NSCLC; Sox2; Oct4; immunohistochemistry; RT-PCR; Western blot NSCLC; Sox2; Oct4; immunohistochemistry; RT-PCR; Western blot
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Li, X.; Wang, J.; Xu, Z.; Ahmad, A.; Li, E.; Wang, Y.; Qin, S.; Wang, Q. Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer. Int. J. Mol. Sci. 2012, 13, 7663-7675.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top